1 unknown, 1 withdrawn. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow E2Bio Life Sciences, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a New Medical Device for Oral Mucositis Bocaliner - Oral Mucositis, Stem Cell Transplant Complications | Early Phase 1 | Withdrawn | E2Bio Life Sciences, LLC | 2024-11-30 | 2026-09-11 | |
| Study for the Prevention of Oral Mucositis (SPOM) Bocaliner, Benzydamine - Oral Mucositis | Phase 1 / Phase 2 | Unknown | E2Bio Life Sciences, LLC | 100 | 2022-04-15 | 2023-09-08 |
Stomatitis (2) · Inflammation (1) · Neoplasms (1) · Oral Ulcer (1) · Pain (1)
Anti-Inflammatory Agents (1) · Benzydamine (1)
Armenia (2)
Yervand Hakoban, MD PhD (1) · Yervand Hakobyan, MD (1)
PMID 16601950, PMID 18298885, PMID 24615748, PMID 26409924, PMID 30990550, PMID 40742572